(VIANEWS) – Blackrock MuniYield New York Quality FundCommon Stock (MYN), SuRo Capital Corp. (SSSS), Ameren (AEE) are the highest payout ratio stocks on this list.

We have gathered information about stocks with the highest payout ratio as yet. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.

When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.

1. Blackrock MuniYield New York Quality FundCommon Stock (MYN)

74.76% Payout Ratio

BlackRock MuniYield New York Quality Fund, Inc. is a closed ended fixed income mutual fund launched by BlackRock, Inc. It is managed by BlackRock Advisors, LLC.

Volume

Today’s last reported volume for Blackrock MuniYield New York Quality FundCommon Stock is 36099, 27.97% below its average volume of 50122.

As claimed by Morningstar, Inc., the next dividend payment is on Jan 12, 2022, the estimated forward annual dividend rate is 0.62 and the estimated forward annual dividend yield is 4.34%.

Year-on-year quarterly revenue growth declined by 6.3%, now sitting on 32.37M for the twelve trailing months.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.6%.

Volatility

Blackrock MuniYield New York Quality FundCommon Stock’s last day, week, and month’s current intraday variation average was 0.08%, 0.80%, and 0.76%, respectively.

Blackrock MuniYield New York Quality FundCommon Stock’s highest amplitude of average volatility was 0.91% (day), 1.47% (last week), and 1.36% (last month), respectively.

Blackrock MuniYield New York Quality FundCommon Stock’s Stock Yearly Top and Bottom Value

Blackrock MuniYield New York Quality FundCommon Stock’s stock is valued at $13.22 at 13:23 EST, below its 52-week high of $14.67 and above its 52-week low of $13.06.

Blackrock MuniYield New York Quality FundCommon Stock’s Moving Average

Blackrock MuniYield New York Quality FundCommon Stock’s worth is below its 50-day moving average of $13.98 and below its 200-day moving average of $14.08.

2. SuRo Capital Corp. (SSSS)

64.13% Payout Ratio

Sutter Rock Capital Corp. is specializing in growth capital, B round and beyond, emerging growth, and pre-IPO investments in late stage venture-backed private companies.

Volume

Today’s last reported volume for SuRo Capital Corp. is 239485, 49.17% below its average volume of 471225.

As claimed by Morningstar, Inc., the next dividend payment is on Dec 29, 2021, the estimated forward annual dividend rate is 7.5 and the estimated forward annual dividend yield is 59.29%.

Year-on-year quarterly revenue growth grew by 28.4%, now sitting on 2.01M for the twelve trailing months.

SuRo Capital Corp.’s sales growth is 28.2% for the current quarter and negative 35% for the next. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 64.23%.

Volatility

SuRo Capital Corp.’s last day, week, and month’s current intraday variation average was 1.15%, 1.03%, and 1.63%, respectively.

SuRo Capital Corp.’s highest amplitude of average volatility was 1.81% (day), 2.28% (last week), and 3.30% (last month), respectively.

SuRo Capital Corp.’s Stock Yearly Top and Bottom Value

SuRo Capital Corp.’s stock is valued at $11.97 at 13:23 EST, way under its 52-week high of $16.40 and higher than its 52-week low of $11.04.

SuRo Capital Corp.’s Moving Average

SuRo Capital Corp.’s value is below its 50-day moving average of $12.45 and below its 200-day moving average of $13.27.

3. Ameren (AEE)

57.97% Payout Ratio

Volume

Today’s last reported volume for Ameren is 384223, 68.91% below its average volume of 1236080.

As claimed by Morningstar, Inc., the next dividend payment is on Dec 6, 2021, the estimated forward annual dividend rate is 2.2 and the estimated forward annual dividend yield is 2.64%.

Ameren’s sales growth this year is anticipated to be 6.1% and 4.4% for next year.

Year-on-year quarterly revenue growth grew by 5.5%, now sitting on 5.74B for the twelve trailing months.

Ameren’s sales growth is 7.9% for the present quarter and 5.9% for the next. The company’s growth estimates for the current quarter is 8.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.4%.

Volatility

Ameren’s last day, week, and month’s current intraday variation average was 0.37%, 0.27%, and 0.87%, respectively.

Ameren’s highest amplitude of average volatility was 1.01% (day), 1.03% (last week), and 1.71% (last month), respectively.

Ameren’s Stock Yearly Top and Bottom Value

Ameren’s stock is valued at $86.10 at 13:23 EST, below its 52-week high of $90.77 and way above its 52-week low of $69.79.

Ameren’s Moving Average

Ameren’s value is higher than its 50-day moving average of $84.29 and above its 200-day moving average of $83.91.

Previous days news about Ameren (AEE)

  • According to Bloomberg Quint on Tuesday, 8 February, "Among the participants will be Southern Co. Chief Executive Officer Tom Fanning, American Electric Power Co Inc. Chief Executive Officer Nick Akins, Edison International Chief Executive Officer Pedro Pizarro, Ameren Corp. Executive Chairman Warner Baxter, Exelon Corp. Senior Vice President and Chief Operating Officer Calvin Butler, and DTE Energy Co. Chairman Gerry Anderson, company officials confirmed."

4. Novo Nordisk A/S (NVO)

47.46% Payout Ratio

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide.

Volume

Today’s last reported volume for Novo Nordisk A/S is 573808, 59.32% below its average volume of 1410800.

According to Morningstar, Inc., the next dividend payment is on Aug 15, 2021, the estimated forward annual dividend rate is 1.47 and the estimated forward annual dividend yield is 1.45%.

Novo Nordisk A/S’s sales growth this year is anticipated to be 7.3% and 8.3% for next year.

Year-on-year quarterly revenue growth grew by 10.1%, now sitting on 129.91B for the twelve trailing months.

Novo Nordisk A/S’s sales growth is 7.9% for the present quarter and 11.2% for the next. The company’s growth estimates for the present quarter and the next is 6.9% and 12.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 70.63%.

Volatility

Novo Nordisk A/S’s last day, week, and month’s current intraday variation average was 4.30%, 2.22%, and 2.69%, respectively.

Novo Nordisk A/S’s highest amplitude of average volatility was 1.75% (day), 1.56% (last week), and 1.72% (last month), respectively.

Novo Nordisk A/S’s Stock Yearly Top and Bottom Value

Novo Nordisk A/S’s stock is valued at $104.82 at 13:23 EST, below its 52-week high of $115.95 and way higher than its 52-week low of $66.59.

Novo Nordisk A/S’s Moving Average

Novo Nordisk A/S’s worth is below its 50-day moving average of $107.59 and way higher than its 200-day moving average of $90.32.

5. Camelot Capital Partners, LLC (BBD)

36.84% Payout Ratio

Banco Bradesco S.A., together with its subsidiaries, provides various banking products and financial services to individuals, corporates, and businesses in Brazil and internationally.

Volume

Today’s last reported volume for Camelot Capital Partners, LLC is 21391500, 46.52% below its average volume of 40000400.

As stated by Morningstar, Inc., the next dividend payment is on Aug 2, 2021, the estimated forward annual dividend rate is 0.04 and the estimated forward annual dividend yield is 0.97%.

Camelot Capital Partners, LLC’s sales growth this year is expected to be 4.5% and 6.9% for next year.

Year-on-year quarterly revenue growth grew by 61.3%, now sitting on 91.33B for the twelve trailing months.

Camelot Capital Partners, LLC’s sales growth is negative 1.8% for the current quarter and 11.3% for the next. The company’s growth estimates for the ongoing quarter is 20%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.04%.

Volatility

Camelot Capital Partners, LLC’s last day, week, and month’s current intraday variation average was 9.67%, 2.41%, and 1.70%, respectively.

Camelot Capital Partners, LLC’s highest amplitude of average volatility was 2.30% (day), 2.88% (last week), and 2.67% (last month), respectively.

Camelot Capital Partners, LLC’s Stock Yearly Top and Bottom Value

Camelot Capital Partners, LLC’s stock is valued at $4.05 at 13:23 EST, way below its 52-week high of $5.70 and way above its 52-week low of $3.39.

Camelot Capital Partners, LLC’s Moving Average

Camelot Capital Partners, LLC’s worth is higher than its 50-day moving average of $3.73 and below its 200-day moving average of $4.45.

LEAVE A REPLY

Please enter your comment!
Please enter your name here